Stericycle’s (SRCL) “Underperform” Rating Reiterated at RBC Capital Markets
RBC Capital Markets restated their underperform rating on shares of Stericycle Inc. (NASDAQ:SRCL) in a research note published on Monday morning. They currently have a $77.00 target price on the stock, down from their prior target price of $89.00.
SRCL has been the topic of a number of other reports. Zacks Investment Research lowered shares of Stericycle from a buy rating to a hold rating in a research report on Thursday, July 14th. Imperial Capital reduced their target price on shares of Stericycle from $100.00 to $95.00 and set an in-line rating on the stock in a research report on Thursday, May 26th. Royal Bank Of Canada reiterated a sell rating on shares of Stericycle in a research report on Thursday, May 26th. Finally, Jefferies Group reiterated a buy rating and set a $125.00 target price (down from $140.00) on shares of Stericycle in a research report on Friday, July 29th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $110.32.
Stericycle (NASDAQ:SRCL) opened at 78.00 on Monday. Stericycle has a 52-week low of $76.76 and a 52-week high of $151.57. The stock has a market capitalization of $6.63 billion, a PE ratio of 27.46 and a beta of 0.27. The firm’s 50-day moving average is $84.48 and its 200 day moving average is $102.42.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.18. The firm had revenue of $891.60 million for the quarter, compared to analysts’ expectations of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The company’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 earnings per share. On average, equities analysts forecast that Stericycle will post $4.67 earnings per share for the current year.
In other news, EVP John P. Schetz sold 1,398 shares of the stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the sale, the executive vice president now owns 1,088 shares of the company’s stock, valued at $89,052.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Mark C. Miller sold 34,835 shares of the stock in a transaction on Friday, July 8th. The stock was sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the sale, the director now directly owns 244,284 shares of the company’s stock, valued at approximately $25,532,563.68. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by company insiders.
Large investors have recently modified their holdings of the company. Jana Partners LLC bought a new stake in shares of Stericycle during the first quarter valued at about $305,997,000. Generation Investment Management LLP bought a new stake in shares of Stericycle during the second quarter valued at about $237,333,000. Baillie Gifford & Co. increased its stake in shares of Stericycle by 77.2% in the second quarter. Baillie Gifford & Co. now owns 2,940,515 shares of the company’s stock valued at $306,166,000 after buying an additional 1,281,519 shares in the last quarter. Swedbank bought a new stake in shares of Stericycle during the second quarter valued at about $104,155,000. Finally, USS Investment Management Ltd bought a new stake in shares of Stericycle during the first quarter valued at about $80,866,000. 92.80% of the stock is owned by institutional investors.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.